MarketBeat Instant News Alerts 2 hours agoLyntris Inc. (NYSE:LYNX) Receives Consensus Recommendation of "Buy" from BrokeragesMarketBeatLyntris Inc. (NYSE:LYNX - Get Free Report) has received a consensus rating of "Buy" from the five brokerages that are presently covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have iNYSE:LYNXRead Lyntris Inc. (NYSE:LYNX) Receives Consensus Recommendation of "Buy" from Brokerages2 hours agoAdagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Average Recommendation of "Moderate Buy" by AnalystsMarketBeatAdagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have issued a buy recommendNASDAQ:ADAGRead Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Average Recommendation of "Moderate Buy" by Analysts2 hours agoKiet Huynh Acquires 5 Shares of Rotork (LON:ROR) StockMarketBeatRotork plc (LON:ROR - Get Free Report) insider Kiet Huynh bought 5 shares of the company's stock in a transaction on Thursday, September 10th. The stock was bought at an average price of GBX 3,100 per share, with a total value of £155. LON:RORRead Kiet Huynh Acquires 5 Shares of Rotork (LON:ROR) Stock2 hours agoDefinium Therapeutics' (DFTX) Buy Rating Reiterated at Needham & Company LLCMarketBeatNeedham & Company LLC reissued a "buy" rating and set a $66.00 price objective on shares of Definium Therapeutics in a report on Monday.NASDAQ:DFTXRead Definium Therapeutics' (DFTX) Buy Rating Reiterated at Needham & Company LLC2 hours agoEnergy Recovery (NASDAQ:ERII) Receives Neutral Rating from Seaport Research PartnersMarketBeatSeaport Research Partners restated a "neutral" rating on shares of Energy Recovery in a report on Monday.NASDAQ:ERIIRead Energy Recovery (NASDAQ:ERII) Receives Neutral Rating from Seaport Research Partners2 hours agoKeyCorp Begins Coverage on Jack Henry & Associates (NASDAQ:JKHY)MarketBeatKeyCorp assumed coverage on Jack Henry & Associates in a research report on Monday. They set an "overweight" rating and a $190.00 price objective for the company.NASDAQ:JKHYRead KeyCorp Begins Coverage on Jack Henry & Associates (NASDAQ:JKHY) Trending News1NIO Inc. $NIO Shares Bought by Hsbc Holdings PLC2Comcast Details Split Plan as Broadband, Wireless Competition Intensifies3IREN Limited $IREN Shares Acquired by California State Teachers Retirement System4Vertiv (NYSE:VRT) Stock Price Down 5.9% - Here's Why5SELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 4.8% - Here's Why6Intel (NASDAQ:INTC) Stock Rating Upgraded by Piper Sandler7Intel (NASDAQ:INTC) Shares Down 5.6% - Here's What Happened8Bloom Energy (NYSE:BE) Shares Down 4.3% - Here's Why All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoFreshworks (NASDAQ:FRSH) Now Covered by Analysts at KeyCorpMarketBeatNASDAQ:FRSHRead Freshworks (NASDAQ:FRSH) Now Covered by Analysts at KeyCorp2 hours agoFigma (NYSE:FIG) Coverage Initiated by Analysts at KeyCorpMarketBeatNYSE:FIGRead Figma (NYSE:FIG) Coverage Initiated by Analysts at KeyCorp2 hours agoSolid Biosciences (NASDAQ:SLDB) Earns "Buy" Rating from HC WainwrightMarketBeatNASDAQ:SLDBRead Solid Biosciences (NASDAQ:SLDB) Earns "Buy" Rating from HC Wainwright2 hours agoAddus HomeCare (NASDAQ:ADUS) Given Neutral Rating at Bank of AmericaMarketBeatNASDAQ:ADUSRead Addus HomeCare (NASDAQ:ADUS) Given Neutral Rating at Bank of America2 hours ago4D Molecular Therapeutics (NASDAQ:FDMT) Upgraded to "Overweight" at Cantor FitzgeraldMarketBeatNASDAQ:FDMTRead 4D Molecular Therapeutics (NASDAQ:FDMT) Upgraded to "Overweight" at Cantor Fitzgerald2 hours agoAdagene (NASDAQ:ADAG) Receives Buy Rating from HC WainwrightMarketBeatNASDAQ:ADAGRead Adagene (NASDAQ:ADAG) Receives Buy Rating from HC Wainwright2 hours agoSky Harbour Group (NYSE:SKYH) Receives "Buy" Rating from BTIG ResearchMarketBeatNYSE:SKYHRead Sky Harbour Group (NYSE:SKYH) Receives "Buy" Rating from BTIG Research2 hours agoHyperfine (NASDAQ:HYPR) Given Buy Rating at BTIG ResearchMarketBeatNASDAQ:HYPRRead Hyperfine (NASDAQ:HYPR) Given Buy Rating at BTIG Research2 hours agoHC Wainwright Increases Spero Therapeutics (NASDAQ:SPRO) Price Target to $6.00MarketBeatNASDAQ:SPRORead HC Wainwright Increases Spero Therapeutics (NASDAQ:SPRO) Price Target to $6.002 hours agoInflaRx (NASDAQ:IFRX) Earns Buy Rating from Analysts at Needham & Company LLCMarketBeatNASDAQ:IFRXRead InflaRx (NASDAQ:IFRX) Earns Buy Rating from Analysts at Needham & Company LLC2 hours agoGSI Technology (NASDAQ:GSIT) Coverage Initiated by Analysts at Needham & Company LLCMarketBeatNASDAQ:GSITRead GSI Technology (NASDAQ:GSIT) Coverage Initiated by Analysts at Needham & Company LLC2 hours agoPharming Group's (PHAR) "Buy" Rating Reiterated at HC WainwrightMarketBeatNASDAQ:PHARRead Pharming Group's (PHAR) "Buy" Rating Reiterated at HC Wainwright2 hours agoSolventum (NYSE:SOLV) Given Buy Rating at BTIG ResearchMarketBeatNYSE:SOLVRead Solventum (NYSE:SOLV) Given Buy Rating at BTIG Research2 hours agoHC Wainwright Reaffirms Buy Rating for Genmab A/S (NASDAQ:GMAB)MarketBeatNASDAQ:GMABRead HC Wainwright Reaffirms Buy Rating for Genmab A/S (NASDAQ:GMAB)2 hours agoAscendiant Capital Markets Forecasts Strong Price Appreciation for Duos Technologies Group (NASDAQ:DUOT) StockMarketBeatNASDAQ:DUOTRead Ascendiant Capital Markets Forecasts Strong Price Appreciation for Duos Technologies Group (NASDAQ:DUOT) Stock2 hours agoVertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts AheadMarketBeatNASDAQ:VRTXRead Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead2 hours agoLatigo Biotherapeutics, Inc. (NASDAQ:LTGO) Short Interest Up 129.5% in AugustMarketBeatNASDAQ:LTGORead Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) Short Interest Up 129.5% in August2 hours agoCanterbury Park Holding Corporation (NASDAQ:CPHC) Short Interest UpdateMarketBeatNASDAQ:CPHCRead Canterbury Park Holding Corporation (NASDAQ:CPHC) Short Interest Update2 hours agoGold.com Inc. (NYSE:GOLD) to Issue $0.20 Special DividendMarketBeatNYSE:GOLDRead Gold.com Inc. (NYSE:GOLD) to Issue $0.20 Special Dividend2 hours agoDole PLC Announces Quarterly Dividend of $0.09 (NYSE:DOLE)MarketBeatNYSE:DOLERead Dole PLC Announces Quarterly Dividend of $0.09 (NYSE:DOLE)2 hours agoHCA Healthcare, Inc. (NYSE:HCA) Announces $0.78 Quarterly DividendMarketBeatNYSE:HCARead HCA Healthcare, Inc. (NYSE:HCA) Announces $0.78 Quarterly Dividend2 hours agoOxford Square Capital Corp. (NASDAQ:OXSQ) Plans $0.04 Monthly DividendMarketBeatNASDAQ:OXSQRead Oxford Square Capital Corp. (NASDAQ:OXSQ) Plans $0.04 Monthly Dividend2 hours agoBackblaze, Inc. (NASDAQ:BLZE) Short Interest UpdateMarketBeatNASDAQ:BLZERead Backblaze, Inc. (NASDAQ:BLZE) Short Interest Update3 hours agoThe Hain Celestial Group (NASDAQ:HAIN) Issues Earnings ResultsMarketBeatNASDAQ:HAINRead The Hain Celestial Group (NASDAQ:HAIN) Issues Earnings Results Featured Articles and OffersTesla’s Robotaxi Launch Wasn’t the Moment Investors ExpectedBy Sam Quirke | September 8, 2026Why I went to Mount RushmoreFrom Stansberry Research (Ad)Ride-Share Reckoning: Tesla Drives Into Uber's LaneBy Jeffrey Neal Johnson | September 7, 2026AeroVironment's Record Backlog and Earnings Beat Fuel Recovery CaseBy Thomas Hughes | September 10, 20263 Under-the-Radar Defense Stocks With Record BacklogsBy Dan Schmidt | September 7, 2026NNVC on Alert: FDA Validation and Outperform Rating!From Equiscreen (Ad)Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI DealBy Jeffrey Neal Johnson | September 9, 2026These 3 Risky Stocks Could Be Sitting on 100% UpsideBy Nathan Reiff | September 7, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 355 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
